Siphonaxanthin inhibits the growth of breast cancer cell subtypes by modulating the expression of cellular proteins

Yogendra Prasad Kavalappa1,2, Nimish Mol Stephen3, Kirubakaran Baskaran Jayalakshmi4

  • 1Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute (CFTRI), Mysuru, 570 020, India.

Insights

Marine carotenoid siphonaxanthin (SPX) from Codium species inhibits breast cancer cell growth by suppressing antioxidant and survival pathways, promoting apoptosis. This highlights SPX

Area of Science:

  • Marine natural products
  • Cancer biology
  • Molecular pharmacology

Background:

  • Codium species are edible marine algae with reported health benefits.
  • Marine compounds, including carotenoids, show potential anticancer properties.
  • The molecular mechanisms of Codium-derived compounds in cancer are not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms of siphonaxanthin (SPX) from Codium sp. in inhibiting breast cancer cell growth.
  • To analyze the effects of SPX on cell viability, antioxidant defense, cell survival, and apoptosis signaling pathways.

Main Methods:

  • Cell viability was assessed using the WST-1 assay.
  • Protein expression of key signaling molecules was analyzed via western blotting.
  • Apoptosis induction was visualized using DAPI staining.

Main Results:

  • Siphonaxanthin (SPX) significantly inhibited the viability of MCF-7 and MDA-MB-231 breast cancer cells at 5 μM.
  • SPX suppressed the protein expression of SOD-2, Nrf2, pAkt, pERK1/2, and NF-kB.
  • SPX treatment led to apoptosis induction, evidenced by downregulated Bcl-2, p-Bad, and PARP expression.

Conclusions:

  • Siphonaxanthin (SPX) exhibits a significant cancer chemopreventive role in human breast cancer cells.
  • SPX activates cell death pathways by modulating antioxidant defense and cell survival signaling.
  • Marine carotenoids like SPX represent potential therapeutic agents for breast cancer treatment.